Poseida Therapeutics Inc (PSTX)
9.49
+0.01
(+0.11%)
USD |
NASDAQ |
Dec 24, 16:00
Poseida Therapeutics Profit Margin (Quarterly): 28.20% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Galectin Therapeutics Inc | -- |
| Revance Therapeutics Inc | -63.65% |
| Sage Therapeutics Inc | -788.1% |
| Alector Inc | -275.2% |
| Phathom Pharmaceuticals Inc | -523.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.04% |
| Return on Assets | -21.23% |
| Return on Invested Capital | -40.32% |
| Operating Margin (Quarterly) | 27.52% |
| Return on Net Operating Assets | -106.7% |